Want to see JP:4554 full AI Analyst Report?
Fuji Pharma Co., Ltd. (4554) Financial Statements
Fuji Pharma Co., Ltd. Financial Overview
Fuji Pharma Co., Ltd.'s market cap is currently $48.76B. The company's EPS TTM is $118.97; its P/E ratio is 15.72; and it has a dividend yield of 2.15%. Fuji Pharma Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 51.68B | $ 46.14B | $ 40.89B | $ 35.43B | $ 33.99B |
| Gross Profit | $ 19.29B | $ 16.51B | $ 15.37B | $ 13.62B | $ 14.13B |
| Operating Income | $ 4.99B | $ 3.88B | $ 3.86B | $ 3.78B | $ 3.35B |
| EBITDA | $ 8.96B | $ 7.56B | $ 6.88B | $ 6.52B | $ 5.46B |
| Net Income | $ 3.00B | $ 6.15B | $ 3.44B | $ 2.70B | $ 2.43B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.25B | $ 4.58B | $ 2.32B | $ 3.55B | $ 10.20B |
| Total Assets | $ 93.63B | $ 90.58B | $ 86.40B | $ 75.97B | $ 64.26B |
| Total Debt | $ 30.94B | $ 29.25B | $ 28.95B | $ 24.57B | $ 18.66B |
| Net Debt | $ 23.69B | $ 24.67B | $ 26.62B | $ 21.02B | $ 8.46B |
| Total Liabilities | $ 46.72B | $ 45.01B | $ 45.22B | $ 40.17B | $ 31.58B |
| Stockholders' Equity | $ 46.91B | $ 45.56B | $ 41.17B | $ 35.80B | $ 32.68B |
| Cash Flow | |||||
| Free Cash Flow | $ 3.82B | $ 1.37B | $ -1.41B | $ -5.75B | $ 2.20B |
| Operating Cash Flow | $ 5.80B | $ 4.15B | $ 1.92B | $ -658.00M | $ 5.99B |
| Investing Cash Flow | $ -4.22B | $ -1.66B | $ -5.24B | $ -11.27B | $ -2.35B |
| Financing Cash Flow | $ 954.00M | $ -435.00M | $ 1.92B | $ 5.09B | $ -5.43B |
Currency in JPY